ProShare Advisors LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 51 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$10,503
-4.4%
13,466
+33.6%
0.00%
Q1 2023$10,984
-37.1%
10,077
-15.8%
0.00%
Q4 2022$17,463
+34.3%
11,961
-1.0%
0.00%
Q3 2022$13,000
-27.8%
12,085
+12.7%
0.00%
Q2 2022$18,000
-37.9%
10,724
-24.5%
0.00%
Q1 2022$29,000
-59.7%
14,203
-26.5%
0.00%
Q4 2021$72,000
-52.3%
19,315
-34.0%
0.00%
Q3 2021$151,000
+45.2%
29,273
+19.4%
0.00%
Q2 2021$104,000
+4.0%
24,520
+30.1%
0.00%
Q1 2021$100,000
-11.5%
18,840
-10.3%
0.00%
Q4 2020$113,000
+232.4%
21,005
-6.6%
0.00%
Q3 2019$34,000
-64.6%
22,483
-5.8%
0.00%
-100.0%
Q2 2019$96,000
-17.9%
23,863
-12.5%
0.00%0.0%
Q1 2019$117,000
-21.5%
27,268
+5.1%
0.00%0.0%
Q4 2018$149,000
-59.4%
25,944
-4.2%
0.00%
-50.0%
Q3 2018$367,000
+11.9%
27,090
-1.9%
0.00%0.0%
Q2 2018$328,000
-2.7%
27,606
-8.0%
0.00%0.0%
Q1 2018$337,000
+60.5%
30,005
-4.7%
0.00%
+100.0%
Q4 2017$210,00031,4840.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 12,025,999$66,263,0002.30%
Abingworth LLP 250,000$1,375,0001.02%
Tekla Capital Management LLC 1,466,368$8,080,0000.31%
Rock Springs Capital Management LP 875,000$4,821,0000.28%
QVT Financial LP 1,360,647$6,940,0000.22%
Vident Investment Advisory, LLC 232,641$1,282,0000.13%
Hillhouse Capital Management 1,190,476$6,560,0000.13%
Orbimed Advisors 1,914,660$10,550,0000.12%
Granite Investment Partners, LLC 195,571$1,078,0000.07%
Monashee Investment Management LLC 25,000$138,0000.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders